Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

On Thursday, March 9, the Association of Community Cancer Centers welcomed its members in D.C. for its 49th Annual Meeting & Cancer Center—the oncology conference dedicated to exploring cutting-edge solutions to persistent challenges and navigating the shifting cancer care landscape.
CO-CHAIRS Chair of East & West Joyce O’Shaughnessy, MD US Oncology Dallas, TX Co-Chair of West Sara Hurvitz, MD David Geffen School of Medicine at UCLA Santa Monica, CA 40% OFF Register with code IBCSAP IN-PERSON REGISTRATION Accreditation/Credit Designation Physicians’ Education Resource®, LLC, designates this live activity for AMA PRA Category 1 Credits™. Physicians should …
Before opening the ACCC 49th Annual Meeting & Cancer Center Business Summit to its membership, ACCC held two pre-conference events on Wednesday, March 8. Learn more about what was discussed among invited speakers during these events.
As myeloproliferative neoplasms (MPNs) carry a significant symptom burden and oftentimes can require lifelong care coordination and close monitoring, hear how a strong multidisciplinary approach can impact shared decision-making and patient engagement.
WASHINGTON, D.C. - The Association of Community Cancer Centers (ACCC) is truly “a community of cancer centers,” representing members nationwide from all care delivery settings: health systems, comprehensive cancer programs, academic centers, community cancer programs, and private practices. ACCC educates and advocates on behalf of its members to ensure they can provide high quality, comprehensive …
ACCC_SCLC_Publication_8x10.75_Round8.indd ASSOCIATION OF COMMUNITY CANCER CENTERS Examining Patient-Centered Small Cell Lung Cancer Care: PATIENT AND PROVIDER PERSPECTIVES BACKGROUND INFORMATION To uncover barriers in obtaining optimal care for patients with small cell lung cancer (SCLC), the Association of Community Cancer Centers (ACCC) conducted patient and provider …
March 8, 2023
The ACCC 49th Annual Meeting & Cancer Business Summit (AMCCBS) will offer countless opportunities to collaborate, grow, and transform. Executives from across the healthcare leadership community will come together March 8-10, 2023 at the Capital Hilton in Washington, D.C. to explore cutting-edge solutions to persistent challenges and navigate our shifting cancer care landscape.
For 2023, ACCC members have identified four core areas of focus (e.g., reimbursement, utilization management, provider-patient choice), among a larger set of issues and concerns, that the association will be supporting this year.
State Policy Update Aaron Segel, Associate Director, State Advocacy Association for Clinical Oncology Why State Advocacy? • Legislative action at the state level is increasingly shaping cancer care and the practice of oncology • A law enacted in one state can create a model for other states • States serve as incubators for federal policymaking State Advocacy …
Indiana Oncology Society (IOS) Fort Wayne Lung Cancer Summit: Improving Lung Cancer Outcomes in Our Community AGENDA 6:00 PM Registration and Reception in Resource Center 6:45 PM Opening Remarks Mary Miller, MSN RN-BC OCN President, Indiana Oncology Society Foundation Professor of Lung Cancer 6:50 PM End Lung Cancer Now Nasser H. Hanna, MD Clinical Research …
To Provide Exceptional Cancer Care That Places You at The Center of All We Do Why Survivorship? Heather Dommer MSN, ARNP, FNP-C Nassif Community Cancer Center Survivorship Clinic Objectives • Define Survivorship and give some statistics. • Review the history of our Survivorship clinic. • Discuss the NCCN Standards for Survivorship Care. • Further discuss how we implement these …
www.aftercancer.co www.allofmeiowa.org Erin Sullivan Wagner Preferred pronouns she/her/hers www.aftercancer.co www.allofmeiowa.org SIDE EFFECTS Cancer Treatments: Surgery - Radiation - Chemotherapy - Hormone Nerve Damage Infertility Loss of Limb Fatigue Hormone Changes Hair Loss Intercourse Inability Pain Weight Gain/Loss Menopause Symptoms Mucositis Memory/Focus …
ACCC President Dr. David R. Penberthy's final Tech Talk featured 4 panelists, who shared their perspectives on how technologies like artificial intelligence, machine learning, and the use of big data are currently impacting cancer care delivery, as well as their vision of the ideal future state.
Over half of patients newly diagnosed with multiple myeloma are not eligible for transplant due to age or other major health problems. Listen as Dr. Yee provides treatment planning options available to patients who are ineligible for transplant.
TACOS Spring Conference April 22, 2023 AGENDA Saturday, April 22, 2023 8:00 AM Registration Open / Resource Center 9:00 AM Welcome & Introductions Tomislav Dragovich, MD, PhD President, The Arizona Clinical Oncology Society Banner Md Anderson Cancer Canter Raju Vaddepally, MD President Elect, The Arizona Clinical Oncology Society Yuma Regional Medical Center …
Microsoft Word - AMCCBS Best of CCC Front Matter 3.3.23.docx Best of Community Cancer Care Workshop at AMCCBS March 8, 2023 Washington DC | District of Columbia At the end of this educational activity, participants should be able to: • Review highlights of the advances in clinical and translational research presented at recent national clinical conferences • Provide opportunities …
Advances in HER2 Positive Breast Cancer The ESHOS Review of San Antonio Breast Cancer Symposium Ajay Dhakal MBBS Wilmot Cancer Institute University of Rochester Medical Center Disclosures • Advisory Board: Gilead, AstraZeneca • Honorarium: MJH Life Sciences (OncLive), WebMD Slides from past conferences: Permission received from original presenters (Hurvitz, …
White title slide Molecular Tumor Board Mark E. Burkard MD PhD Mary and Rob Gooze Chair in Metastatic Breast Cancer University of Wisconsin- Madison Disclosures M.E.B. declares the following: • Strata Oncology (Medical Advisory Board) • Abbvie, Arcus, Apollomics, Elevation Oncology, Genentech, Puma, Loxo Oncology, Seagen (Research funding) • Novartis, Strata Oncology …
Advances in HER2 Positive Breast Cancer The ESHOS Review of San Antonio Breast Cancer Symposium Ajay Dhakal MBBS Wilmot Cancer Institute University of Rochester Medical Center Disclosures • Advisory Board: Gilead, AstraZeneca • Honorarium: MJH Life Sciences (OncLive), WebMD Slides from past conferences: Permission received from original presenters (Hurvitz, …